Discussing whether a new $487M investment from the government will help speed up the production of the most important vaccines, with Kathy S...
Novartis is opening on Tuesday the country's first plant to produce flu vaccines using cell cultures. These vaccines are faster, better and ...
Novartis is opening on Tuesday the country's first plant to produce flu vaccines using cell cultures. These vaccines are faster, better and ...
Protection of intellectual property rights in China has improved in the last few years, says Steve Yang, vice president and head of R&D Asia...
A new study is putting Merck's cholesterol drugs under pressure today, reports CNBC's Mike Huckman, with Ken Frazier, Merck Global Human Hea...
Abbott Laboratories' Niaspan beat Merck's Zetia in a new study. CNBC's Mike Huckman has the details.
Posts |
COMPANY : Amylin Pharmaceuticals
2 Nov 2009
Over the past few days there's been a remarkable confluence of newsflow, most of it positive, out of biopharma... Read More
31 Aug 2009
After a long delay, Eli Lilly finally launched its new bloodthinner Effient just this month... Read More
13 Aug 2009
Big money managers can instill confidence in individual stocks and you may be able to profit off their moves... Read More
31 Jul 2009
Everyone’s talking about the July stock market rally... Read More
14 Jul 2009
For years now, but especially in recent months, I've been covering the obesity epidemic... Read More
News |
COMPANY : Amylin Pharmaceuticals
Thursday, 22 Oct 2009
Wednesday, 27 May 2009
About CNBC | Site Map | Privacy Policy | Terms of Service | Video Reprints | Advertise | Help | Contact
Partners: AOL Money | BloggingStocks.com
Partners: AOL Money | BloggingStocks.com
Data is a real-time snapshot *Data is delayed at least 15 minutesGlobal Business and Financial News, Stock Quotes, and Market Data and Analysis
© 2009 CNBC, Inc. All Rights Reserved.
A Division of NBC Universal
